CSF3 and type 2 diabetes mellitus: In light of the fact that 70–80% patients who succumb to sepsis harbor persistent, chronic, ongoing, or secondary infections (13), G-CSF or GM-CSF combined with other immune regulators may bolster immune response and eradicate infection in septic T2D populations, potentially improving overall survival (254, 261).